Journal
Fridays Review 2026: $175 Semaglutide, $359 Tirzepatide — One Competitive Lane
Released: Last reviewed:
Short answer — August 2026
Fridays prices its molecules into different markets: semaglutide at one seventy-five — four under Henry, inside the credible monthly band, forty-six over the floor — and tirzepatide at three fifty-nine, provider-stated, in the upper shelf where the brand comparison takes over (ninety under the approved maintenance vial, sixty over the approved 5-milligram rung). One program, two verdicts, familiar shape.
Two lanes, and the questions
The semaglutide lane is genuinely arguable: one seventy-five month-to-month competes with Henry's one seventy-nine on price while the differentiation question — what's bundled, which pharmacy — decides between them; the standard written answers settle it in one intake. The tirzepatide lane argues uphill: three fifty-nine carries a hundred-eighty-to-one-ninety premium over the flat tier without an itemized bundle in our records, and lands in the altitude band where the approved product's certainty wins most neutral comparisons. Fit: semaglutide buyers comparison-shopping the one-seventy-five-to-one-seventy-nine band on service answers; tirzepatide buyers keep walking in either direction.
Questions people ask
How much does Fridays cost?
$175/month for compounded semaglutide and $359 for tirzepatide, provider-stated. The semaglutide figure sits inside the competitive monthly band; the tirzepatide figure lands upper-shelf, $90 under FDA-approved Zepbound's maintenance vial.
Is Fridays good for semaglutide?
It's priced to compete — $4 under Henry's $179 — so the decision moves to service answers: what's included, which pharmacy (then verify), exit terms in writing. On price alone it clears everything above $175 and trails the $129–$149 value cluster.
Why skip Fridays for tirzepatide?
Arithmetic: $359 is $180–$190 over the flat tier for the same molecule, and close enough to the approved product ($299–$449 by dose) that certainty-per-dollar favors the brand for most buyers. Our records show no bundled-service case closing that gap.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.